In our study, we explored NFE2L3 expression in gastric cancer for the first time, constructed an NFE2L3 knockdown cell line to verify the effect of NFE2L3 on gastric cancer cell proliferation and metastasis, and assessed the cell cycle and apoptosis. Here, NFE2L3 is linked to gastric cancer.